- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Legend Biotech Corp (LEGN)
Assess today's live Legend Biotech Corp (LEGN) share price, performance and insights using our live NASDAQ: LEGN stock exchange data.
Analyse the historical data and Legend Biotech Corp share price performance charts on this page. Our technical summary section provides analysis on Legend Bio share price buy/sell indicators using real-time data (or discuss the Legend Bio (LEGN) stock price today with other investors in the Legend Bio NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ LEGN share price (ISIN: US52490G1022) to enhance your trading decisions with our free investment tools and resources.
What Is the Legend Biotech Corp Share Price Today?
The Legend Bio share price today is 22.85.
What Is the Stock Symbol for Legend Biotech Corp
The stock symbol (or 'ticker') for Legend Biotech Corp is "LEGN."
What Stock Exchange Does Legend Biotech Corp Trade On?
Legend Biotech Corp is listed and trades on the NASDAQ stock exchange.
Is Legend Biotech Corp a Good Stock to Buy?
Determining whether Legend Biotech Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Legend Biotech Corp share price performance charts on this page. Our technical summary section provides analysis on Legend Bio share price buy/sell indicators using real-time data (or discuss the Legend Bio (LEGN) stock price today with other investors in the Legend Bio NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ LEGN share price (ISIN: US52490G1022) to enhance your trading decisions with our free investment tools and resources.
What Is the Legend Biotech Corp Share Price Today?
The Legend Bio share price today is 22.85.
What Is the Stock Symbol for Legend Biotech Corp
The stock symbol (or 'ticker') for Legend Biotech Corp is "LEGN."
What Stock Exchange Does Legend Biotech Corp Trade On?
Legend Biotech Corp is listed and trades on the NASDAQ stock exchange.
Is Legend Biotech Corp a Good Stock to Buy?
Determining whether Legend Biotech Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.48
23.21
52 wk Range
21.19
45.30
LEGN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.4823.21
52 wk Range
21.1945.30
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LEGN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
72.24
Upside
+216.15%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Legend Bio Company Profile
Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma (NHL), acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. In addition, it develops allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting B-cell maturation antigen (BCMA) for MM, which are in investigator-initiated Phase 1 clinical trials in China. The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, as well as a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein 3. The company was founded in 2014 and is headquartered in Somerset, New Jersey.
Legend Biotech Corp SWOT Analysis
Carvykti's Triumph | Legend Biotech's flagship product Carvykti drives remarkable 74.75% revenue growth, establishing itself as a leading treatment for multiple myeloma |
Financial Fortitude | Explore Legend Biotech's robust liquidity position, with a current ratio of 4.71 and more cash than debt, despite negative EPS |
Pipeline Potential | Delve into Legend Biotech's diverse pipeline, including promising CAR-T therapies for gastric, esophageal, and lung cancers, offering growth beyond Carvykti |
Market Outlook | Analyst price targets range from $71 to $94, with an average of $82.20, reflecting confidence in Legend Biotech's growth prospects and pipeline potential |
Legend Biotech Corp Earnings Call Summary for Q2/2025
- Q2 2025 revenue of $255.06M exceeded forecasts by 8.89%, driven by strong CarVicti sales growth of 136% YoY
- EPS loss of $0.34 missed expectations; stock rose 2.03% pre-market despite mixed financial performance
- Company anticipates profitability by 2026, with CarVicti operational breakeven expected in 2025
- Expansion of treatment centers underway; executives emphasize importance of early patient referral and treatment
- Challenges include achieving profitability, market competition, and maintaining high manufacturing success rates
Last Updated: 11/08/2025, 14:10
Read Full TranscriptCompare LEGN to Peers and Sector
Metrics to compare | LEGN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLEGNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −17.2x | −2.6x | −0.6x | |
PEG Ratio | −0.54 | 0.13 | 0.00 | |
Price/Book | 4.1x | 3.5x | 2.6x | |
Price / LTM Sales | 4.5x | 196.6x | 3.2x | |
Upside (Analyst Target) | 231.5% | 357.8% | 41.8% | |
Fair Value Upside | Unlock | −1.0% | 5.1% | Unlock |
Analyst Ratings
16 Buy
1 Hold
0 Sell
Ratings:
17 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 72.24
(+216.15% Upside)
Earnings
Latest Release
Nov 12, 2025
EPS / Forecast
-0.11 / -0.0447
Revenue / Forecast
272.33M / 274.72M
People Also Watch
FAQ
What Is the Legend Bio (LEGN) Share Price Today?
The live Legend Bio share price today is 22.85
What Stock Exchange Does Legend Bio (LEGN) Trade On?
Legend Bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Legend Bio?
The stock symbol (also called a 'ticker') for Legend Bio is "LEGN."
What Is the Current Legend Bio Market Cap?
As of today, Legend Bio market capitalisation is 4.22B.
What Is Legend Bio's (LEGN) Earnings Per Share (TTM)?
The Legend Bio EPS is currently -1.30 (Trailing Twelve Months).
When Is the Next Legend Bio Earnings Date?
Legend Bio's next earnings report will be released on 18 Mar 2026.
Is LEGN a Buy or Sell From a Technical Analyst Perspective?
Based on today's Legend Bio moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Legend Bio Stock Split?
Legend Bio has split 0 times. (See the LEGN stock split history page for full effective split date and price information.)
How Many Employees Does Legend Bio Have?
Legend Bio has 2900 employees.
What is the current trading status of Legend Bio (LEGN)?
As of 24 Dec 2025, Legend Bio (LEGN) is trading at a price of 22.85, with a previous close of 22.69. The stock has fluctuated within a day range of 22.48 to 23.21, while its 52-week range spans from 21.19 to 45.30.
What Is Legend Bio (LEGN) Price Target According to Analysts?
The average 12-month price target for Legend Bio is USD72.24, with a high estimate of USD91 and a low estimate of USD48. 16 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +216.15% Upside potential.
What Is the LEGN Premarket Price?
LEGN's last pre-market stock price is 22.70. The pre-market share volume is 24,330.00, and the stock has decreased by 0.01, or 0.04%.
What Is the LEGN After Hours Price?
LEGN's last after hours stock price is 23.23, the stock has decreased by 0.37, or 1.62%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.